Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
clinical trials
fda
gene therapy
genentech
life sciences
national
national blog main
national top stories
new york top stories
novartis
san francisco top stories
zolgensma
2
×
10x genomics
abbvie
allergan
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avexis
billy dunn
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brian kaspar
bristol-myers squibb
cadent therapeutics
celgene
centers for disease control and prevention
chinook therapeutics
clostridium difficile
community-acquired bacterial pneumonia
dana hilt
daprodustat
david chacko
What
fda
2
×
approved
atrophy
august
bio
biotech
busy
daily
days
decisions
devices
drug
drugs
evrysdi
friday
green
home
intended
legacy
lights
liquid
medicine
muscular
new
news
nods
opioid
oral
past
patients
regulatory
risdiplam
roche
roundup
sarepta’s
seven
shkreli’s
slow
spinal
stumble
Language
unset
Current search:
zolgensma
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More